GGT008
Colorectal, gastric, esophageal, pancreatic cancers
Pre‑clinicalActive
Key Facts
Indication
Colorectal, gastric, esophageal, pancreatic cancers
Phase
Pre‑clinical
Status
Active
Company
About Biosyngen
Biosyngen builds first‑in‑class cell‑therapy platforms to treat solid‑tumor cancers with rapid, safe, and scalable manufacturing.
View full company profile